Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis

OBJECTIVES: Neoadjuvant chemoimmunotherapy is the optimal choice in the treatment of NSCLC; however, the optimal number of therapeutic cycles remains unclear. The primary aim of this study was to determine the optimal number of neoadjuvant therapeutic cycles in NSCLC. METHODS: This study was a real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baihua, Guo, Xiaotong, Jia, Ran, Wang, Zhan, Wu, Jie, Chen, Xiaoyan, Li, Jigang, Yang, Desong, Li, Xu, Wang, Wenxiang, Xiao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508959/
https://www.ncbi.nlm.nih.gov/pubmed/37731645
http://dx.doi.org/10.3389/fonc.2023.1200625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508959/
https://www.ncbi.nlm.nih.gov/pubmed/37731645
http://dx.doi.org/10.3389/fonc.2023.1200625

Ejemplares similares